Novo, Kallyope link to develop obesity, diabetes therapies

20th June 2018 Uncategorised 0

Novo Nordisk and Kallyope are joining forces to discover novel peptide therapeutics for obesity and diabetes.

More: Novo, Kallyope link to develop obesity, diabetes therapies
Source: News